Oculus Innovative Sciences Updates Guidance: Faster Path to Positive EBITDAS as Result of Recent Partnership Sep 20, 2012
Photo Release -- Napa Valley Nutritionals Launches Glucorein(TM) Medical Food for Dietary Management of Polycystic Ovary Syndrome (PCOS) Sep 18, 2012
Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Issuance of U.S. Patent for Prevention and Treatment of Peritonitis With Microcyn(R) Technology Sep 11, 2012
Oculus Innovative Sciences to Present at the Rodman & Renshaw 14th Annual Healthcare Conference on September 10th in New York City Sep 5, 2012
Oculus Innovative Sciences Enrolls First Patient in Study of Microcyn(R) Hydrogel in Management of Scars Aug 16, 2012
Oculus Innovative Sciences Announces Licensing of Microcyn(R)-Based Products in Mexico, South/Central America and Caribbean Countries to More Pharma With $5.1 Million Up Front Payment Aug 9, 2012
Oculus Innovative Sciences Reports Record Revenues of $4.1 Million for the First Quarter of Fiscal 2013 Aug 2, 2012
Oculus Innovative Sciences Announces Fiscal First Quarter 2013 Financial Results and Conference Call Jul 25, 2012
Oculus Innovative Sciences Receives Chinese SFDA Regulatory Approval of Microcyn(R) Hydrogel Jul 10, 2012
